GO:0050694 galactose 3-O-sulfotransferase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0050694 galactose 3-O-sulfotransferase activity catalyzes the transfer of sulfate from 3'-phosphoadenosine 5'-phosphosulfate (PAPS) to the 3-OH position of terminal galactose in N-acetyllactosamine (Gal-beta-(1,4)-GlcNAc) and related acceptors.
• The reaction produces 3-sulfo-N-acetyllactosamine and adenosine 3',5'-bisphosphate, modifying glycans on O-glycans, N-glycans, and mucin-type chains.
• Multiple human Gal3ST enzymes (GAL3ST1-4) exhibit distinct substrate preferences: GAL3ST2 prefers globo H backbone, GAL3ST3 prefers N-glycan multiterminal units, and GAL3ST4 prefers mucin core-2 trisaccharide.
• GAL3ST1-mediated histone tyrosine sulfation in cancer-associated fibroblasts promotes gastric cancer metastasis, linking this activity to epigenetic regulation and tumor progression.
• FUT1- and GAL3ST2-mediated glycan remodeling broadly restricts sialic acid-dependent viral infections, highlighting roles in host-pathogen interactions.
• Experimental models for studying this activity include CRISPR knockout, point mutation, knock-in, and overexpression cell lines, combined with glycan profiling and sulfotransferase assays.
Description
Galactose 3-O-sulfotransferase activity (GO:0050694) is a molecular function that catalyzes the transfer of a sulfate group from 3'-phosphoadenosine 5'-phosphosulfate (PAPS) to the 3-OH position of terminal galactose residues in N-acetyllactosamine (Gal-beta-(1,4)-GlcNAc) and related carbohydrate structures. This modification generates 3-sulfo-N-acetyllactosamine and adenosine 3',5'-bisphosphate, and it occurs on a variety of glycoconjugates including O-glycans, N-glycans, and mucin-type chains. The enzyme activity is critical for generating sulfated glycan epitopes that mediate cell-cell recognition, signaling, and pathogen binding. Researchers study galactose 3-O-sulfotransferase activity because sulfated glycans are implicated in diverse biological processes, from immune regulation to cancer metastasis. The human genome encodes several galactose 3-O-sulfotransferases (GAL3ST1-4) with distinct but overlapping substrate specificities, enabling fine-tuned regulation of glycan sulfation patterns. Dysregulation of these enzymes has been linked to tumor progression, viral infection susceptibility, and altered cell surface properties. Understanding the molecular mechanism, substrate range, and regulatory networks of GO:0050694 is therefore essential for both basic glycobiology and translational applications. This article provides a comprehensive overview of GO:0050694, covering its definition, catalytic mechanism, key genes, disease associations, and experimental methods. It is designed for researchers seeking to investigate this activity using CRISPR-based models and advanced glycomic and biochemical assays.
galactose 3-O-sulfotransferase activity At A Glance
| GO ID | GO:0050694 |
|---|---|
| GO term | galactose 3-O-sulfotransferase activity |
| Ontology | molecular_function |
| Synonym | Gal-3-O-sulfotransferase activity; galactose 3-O-sulphotransferase activity |
| Major function | Transfer of sulfate from PAPS to the 3-OH position of terminal galactose in N-acetyllactosamine and related acceptors |
| Reaction | N-acetyllactosamine + 3'-phosphoadenosine 5'-phosphosulfate = 3-sulfo-N-acetyllactosamine + adenosine 3',5'-bisphosphate |
| Substrates | N-acetyllactosamine (Gal-beta-(1,4)-GlcNAc), O-glycans, N-glycans, mucin core-2 trisaccharide, globo H backbone |
| Cofactor | 3'-phosphoadenosine 5'-phosphosulfate (PAPS) |
| Products | 3-sulfo-N-acetyllactosamine, adenosine 3',5'-bisphosphate |
What Is GO:0050694?
GO:0050694 galactose 3-O-sulfotransferase activity is defined as the catalysis of the reaction: N-acetyllactosamine + 3'-phosphoadenosine 5'-phosphosulfate = 3-sulfo-N-acetyllactosamine + adenosine 3',5'-bisphosphate. N-acetyllactosamine residues are found in a number of different carbohydrate types and can also be written as Gal-beta-(1,4)-GlcNAc. This activity transfers a sulfate group to the 3-OH position of galactose, generating a sulfated glycan epitope.
Why Is galactose 3-O-sulfotransferase activity Important in Cell Biology?
Galactose 3-O-sulfotransferase activity is important because it generates sulfated glycan structures that modulate cell surface interactions, immune recognition, and pathogen binding. The activity is mediated by a family of enzymes (GAL3ST1-4) with distinct substrate specificities, and its dysregulation has been linked to cancer progression, viral infection, and altered glycosylation patterns in disease. Understanding this activity provides insights into glycan-mediated biology and offers potential targets for therapeutic intervention.
• Generates 3-sulfated galactose epitopes that are recognized by lectins and antibodies, influencing cell adhesion and signaling.
• Modulates immune cell interactions through sulfated glycan ligands on mucins and other glycoproteins.
• Plays a role in cancer metastasis: GAL3ST1-mediated histone tyrosine sulfation in cancer-associated fibroblasts promotes gastric cancer metastasis.
• Affects host-pathogen interactions: FUT1- and GAL3ST2-mediated glycan remodeling restricts sialic acid-dependent viral infections.
• Contributes to the biosynthesis of sulfated Lewis X and related epitopes involved in selectin binding.
• Distinct substrate preferences among GAL3ST enzymes enable fine-tuned regulation of glycan sulfation in different tissues.
• Alterations in sulfotransferase activity are associated with tumor epithelial cell lines, suggesting roles in cancer biology.
• Provides potential biomarkers and therapeutic targets for diseases involving aberrant glycosylation.
Molecular Mechanism of galactose 3-O-sulfotransferase activity
Substrate Recognition and Binding
In simple terms: The enzyme first grabs the sugar molecule it will modify.
Galactose 3-O-sulfotransferases recognize terminal galactose residues in N-acetyllactosamine (Gal-beta-(1,4)-GlcNAc) units, which can be present on O-glycans, N-glycans, or mucin-type chains. Different GAL3ST isoforms exhibit distinct affinities: GAL3ST2 prefers the globo H backbone, GAL3ST3 prefers N-glycan multiterminal Gal-beta-(1,4)-GlcNAc units, and GAL3ST4 prefers the mucin core-2 trisaccharide. This substrate specificity determines which glycans become sulfated in a given cellular context.
Catalytic Transfer of Sulfate
In simple terms: The enzyme moves a sulfate group from a donor molecule onto the sugar.
The catalytic mechanism involves the transfer of a sulfate group from 3'-phosphoadenosine 5'-phosphosulfate (PAPS) to the 3-OH position of the terminal galactose, yielding 3-sulfo-N-acetyllactosamine and adenosine 3',5'-bisphosphate. This reaction is characteristic of sulfotransferases and requires the cofactor PAPS as the sulfate donor.
Product Formation and Glycan Remodeling
In simple terms: The modified sugar becomes part of a larger glycan structure with new properties.
The 3-sulfated galactose product can be further modified by other glycosyltransferases, leading to complex sulfated epitopes such as (SO4-3)Gal-beta1-4(Fuc-alpha1-3)GlcNAc. These sulfated glycans are involved in cell-cell recognition and can serve as ligands for selectins and other lectins. The activity thus contributes to the overall glycan remodeling that affects cell surface properties.
Regulation by Enzyme Expression and Localization
In simple terms: The amount and location of the enzyme control how much sulfation occurs.
The activity of galactose 3-O-sulfotransferases is regulated at the level of enzyme expression, with different isoforms showing tissue-specific patterns. For example, a novel human galactose 3-O-sulfotransferase was cloned and characterized from human airways, where it sulfates terminal galactose in N-acetyllactosamine-containing mucin carbohydrate chains. Additionally, GAL3ST1-mediated histone tyrosine sulfation induced by cancer-associated fibroblasts demonstrates that the activity can be modulated by the tumor microenvironment.
Key Genes Involved in GO:0050694 galactose 3-O-sulfotransferase activity
The following genes encode enzymes with galactose 3-O-sulfotransferase activity or are directly involved in its regulation and downstream effects.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GAL3ST1 | Galactose 3-O-sulfotransferase that sulfates galactose in glycans; also mediates histone tyrosine sulfation | Linked to gastric cancer metastasis; potential target for cancer therapy |
| GAL3ST2 | Galactose 3-O-sulfotransferase with high affinity for globo H backbone | Involved in glycan remodeling that restricts viral infections |
| GAL3ST3 | Galactose 3-O-sulfotransferase preferring N-glycan multiterminal units | Substrate specificity studies; role in N-glycan sulfation |
| GAL3ST4 | Galactose 3-O-sulfotransferase preferring mucin core-2 trisaccharide | Mucin-type O-glycan sulfation; potential roles in mucosal immunity |
| FUT1 | Fucosyltransferase that works with GAL3ST2 in glycan remodeling | Modulates sialic acid-dependent viral infections |
| CHST1 | Carbohydrate sulfotransferase that may cooperate in sulfated glycan biosynthesis | Related to sulfotransferase family; context-dependent |
| CHST2 | Carbohydrate sulfotransferase involved in sulfated glycan synthesis | Potential crosstalk with galactose 3-O-sulfation |
| CHST3 | Carbohydrate sulfotransferase | Family member with related functions |
| CHST4 | Carbohydrate sulfotransferase | Family member with related functions |
| B3GNT3 | Beta-1,3-N-acetylglucosaminyltransferase that can generate N-acetyllactosamine acceptors | Upstream of galactose 3-O-sulfation |
| B4GALT1 | Beta-1,4-galactosyltransferase that synthesizes N-acetyllactosamine | Provides substrate for galactose 3-O-sulfotransferases |
| PAPSS1 | 3'-Phosphoadenosine 5'-phosphosulfate synthase 1, produces PAPS | Supplies cofactor for sulfation reactions |
| PAPSS2 | 3'-Phosphoadenosine 5'-phosphosulfate synthase 2, produces PAPS | Alternative PAPS source |
| SLC35B2 | PAPS transporter | Regulates PAPS availability in Golgi |
| SLC35B3 | PAPS transporter | Regulates PAPS availability in Golgi |
| GAL3ST1 (histone) | Mediates histone tyrosine sulfation | Epigenetic regulation in cancer |
| GAL3ST2 (viral) | Glycan remodeling restricts viral infection | Host-pathogen interaction |
| GAL3ST4 (mucin) | Sulfates mucin core-2 trisaccharide | Mucin biology and mucosal defense |
How Is galactose 3-O-sulfotransferase activity Regulated?
The activity of galactose 3-O-sulfotransferases is regulated by the availability of the cofactor PAPS, which is synthesized by PAPS synthases (PAPSS1, PAPSS2) and transported into the Golgi by SLC35B2 and SLC35B3. Enzyme expression levels vary by tissue and are influenced by the tumor microenvironment; for instance, cancer-associated fibroblasts induce GAL3ST1-mediated histone tyrosine sulfation in gastric cancer. Additionally, hypoxia-inducible factors can regulate glycosylation pathways, though direct evidence for HIF regulation of galactose 3-O-sulfotransferase activity is not established in the provided citations.
galactose 3-O-sulfotransferase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GAL3ST1 | Gastric cancer metastasis | Knockout or overexpression in gastric cancer cell lines; metastasis assays |
| GAL3ST2 | Viral infection restriction | Knockout in epithelial cells; viral infection assays |
| GAL3ST3 | N-glycan sulfation in cancer | Point mutation to alter substrate specificity; glycan profiling |
| GAL3ST4 | Mucin-type O-glycan sulfation | Knock-in of tagged enzyme; mucin-producing cell lines |
| FUT1 | Sialic acid-dependent viral infections | Overexpression and knockout; viral challenge |
Cancer Metastasis
GAL3ST1-mediated histone tyrosine sulfation induced by cancer-associated fibroblasts promotes gastric cancer metastasis, indicating that galactose 3-O-sulfotransferase activity can contribute to epigenetic changes that drive tumor progression. This suggests that targeting this activity may have therapeutic potential in cancers with high GAL3ST1 expression.
Viral Infections
FUT1- and GAL3ST2-mediated cellular glycan remodeling broadly restricts sialic acid-dependent viral infections, demonstrating that galactose 3-O-sulfotransferase activity can alter host cell susceptibility to viruses. This highlights a role for sulfated glycans in host-pathogen interactions.
Tumor Epithelial Cell Lines
Distinct Gal:3-O-sulfotransferase activities have been characterized in human tumor epithelial cell lines, suggesting that these enzymes are active in cancer cells and may contribute to tumor-specific glycan signatures.
From galactose 3-O-sulfotransferase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of GAL3ST1 affect cancer cell metastasis? | CRISPR knockout of GAL3ST1 in gastric cancer cell lines followed by in vivo metastasis assays |
| What is the substrate specificity of GAL3ST3? | Point mutations in the catalytic domain of GAL3ST3, expressed in cells, followed by glycan analysis |
| Can GAL3ST2 overexpression restrict viral infection? | Knock-in or overexpression of GAL3ST2 in epithelial cells, then viral infection |
| Where is GAL3ST4 localized in cells? | Tagged knock-in of GAL3ST4 with fluorescent protein; imaging |
| Does GAL3ST1-mediated histone sulfation alter gene expression? | Overexpression and knockout of GAL3ST1 in cancer-associated fibroblasts; RNA-seq |
| What is the role of PAPS transporters in sulfation? | Knockout of SLC35B2 or SLC35B3; measure sulfated glycans |
How to Study the galactose 3-O-sulfotransferase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Mass spectrometry glycomics | Structure and abundance of sulfated glycans | Substrate specificity and glycan remodeling |
| Sulfotransferase activity assay | Enzyme kinetics and substrate preference | Characterization of GAL3ST isoforms |
| CRISPR knockout screens | Genes required for sulfated glycan synthesis | Identify regulators of galactose 3-O-sulfation |
| Flow cytometry with anti-sulfate antibodies | Cell surface expression of 3-sulfated epitopes | Phenotyping of cancer cells |
| Immunohistochemistry | Tissue distribution of sulfated glycans | Cancer and normal tissue analysis |
| RNA-seq | Expression levels of GAL3ST genes | Regulation and disease association |
| Western blotting | Protein expression of GAL3ST enzymes | Validation of knockout or overexpression |
| Lectin binding assays | Recognition of sulfated glycans by lectins | Functional studies of glycan-lectin interactions |
Glycan Profiling by Mass Spectrometry
Mass spectrometry-based glycomics can identify and quantify 3-sulfated glycans produced by galactose 3-O-sulfotransferase activity. This method is used to determine substrate specificity and changes in glycan structures upon enzyme knockout or overexpression.
Sulfotransferase Activity Assays
In vitro assays using radiolabeled PAPS or fluorescent substrates measure the transfer of sulfate to acceptor glycans. These assays are used to characterize enzyme kinetics and substrate preferences of GAL3ST isoforms.
CRISPR-Based Genetic Screens
Genome-wide CRISPR knockout screens can identify genes that regulate galactose 3-O-sulfotransferase activity or are required for the synthesis of sulfated glycans. Such screens link the activity to cellular phenotypes.
Antibody-Based Detection of Sulfated Epitopes
Monoclonal antibodies specific for 3-sulfated galactose epitopes can be used in flow cytometry, immunohistochemistry, or Western blotting to detect the products of galactose 3-O-sulfotransferase activity in cells and tissues.
How CRISPR Can Be Used to Study GO:0050694 galactose 3-O-sulfotransferase activity
Knockout
CRISPR knockout of GAL3ST genes (e.g., GAL3ST1, GAL3ST2) eliminates galactose 3-O-sulfotransferase activity, allowing researchers to study loss-of-function phenotypes such as altered glycan profiles, reduced cancer metastasis, or increased viral susceptibility. Knockout cell lines are essential for validating the specific contribution of each isoform.
Point Mutation
Point mutations in the catalytic domain of GAL3ST enzymes can be introduced using CRISPR base editing or homology-directed repair to dissect substrate binding and catalytic residues. Such mutants help define the molecular determinants of substrate specificity and activity.
Knock-in
Knock-in of tagged versions of GAL3ST enzymes (e.g., FLAG, GFP) enables localization studies and interaction proteomics. Knock-in of disease-associated mutations can model altered sulfation in cancer or viral infection.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of GAL3ST genes increases galactose 3-O-sulfotransferase activity, allowing gain-of-function studies. Overexpression of GAL3ST2, for example, restricts sialic acid-dependent viral infections.
How EDITGENE Supports galactose 3-O-sulfotransferase activity Research
Researchers studying galactose 3-O-sulfotransferase activity-related genes often need to determine whether a candidate gene is causally involved in glycan sulfation, disease progression, or host-pathogen interactions. EDITGENE provides a comprehensive suite of CRISPR services to enable such investigations, from knockout to precise point mutations and overexpression models.
Contact EDITGENE today to design your custom CRISPR model for galactose 3-O-sulfotransferase activity research.
Frequently Asked Questions About galactose 3-O-sulfotransferase activity
What is galactose 3-O-sulfotransferase activity?
Galactose 3-O-sulfotransferase activity (GO:0050694) is a molecular function that catalyzes the transfer of sulfate from PAPS to the 3-OH position of terminal galactose in N-acetyllactosamine and related glycans, producing 3-sulfo-N-acetyllactosamine.
What genes are involved in galactose 3-O-sulfotransferase activity?
The main genes are GAL3ST1, GAL3ST2, GAL3ST3, and GAL3ST4, which encode enzymes with distinct substrate specificities.
What is the reaction catalyzed by GO:0050694?
The reaction is: N-acetyllactosamine + 3'-phosphoadenosine 5'-phosphosulfate = 3-sulfo-N-acetyllactosamine + adenosine 3',5'-bisphosphate.
Which diseases are associated with galactose 3-O-sulfotransferase activity?
It has been linked to gastric cancer metastasis through GAL3ST1-mediated histone sulfation, and to viral infection restriction via GAL3ST2 and FUT1.
How can I study galactose 3-O-sulfotransferase activity in the lab?
Common methods include sulfotransferase activity assays, mass spectrometry glycomics, CRISPR knockout screens, and antibody-based detection of sulfated epitopes.
What is the substrate specificity of GAL3ST2?
GAL3ST2 has high affinity for the globo H backbone and is involved in glycan remodeling that restricts viral infections.
Does galactose 3-O-sulfotransferase activity play a role in cancer?
Yes, GAL3ST1-mediated histone tyrosine sulfation induced by cancer-associated fibroblasts promotes gastric cancer metastasis.
What are the synonyms for galactose 3-O-sulfotransferase activity?
Synonyms include Gal-3-O-sulfotransferase activity and galactose 3-O-sulphotransferase activity.
Which cofactor is required for galactose 3-O-sulfotransferase activity?
The cofactor is 3'-phosphoadenosine 5'-phosphosulfate (PAPS), which serves as the sulfate donor.
Can CRISPR be used to study galactose 3-O-sulfotransferase activity?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools to dissect the function of GAL3ST genes and their role in disease.
Conclusion
Galactose 3-O-sulfotransferase activity (GO:0050694) is a key enzymatic function that generates sulfated glycans involved in cell recognition, cancer progression, and host-pathogen interactions. The family of GAL3ST enzymes exhibits distinct substrate specificities, enabling precise regulation of glycan sulfation. Understanding this activity through CRISPR-based models and advanced glycomic methods offers insights into disease mechanisms and potential therapeutic targets. EDITGENE provides comprehensive services to support research on this important molecular function.
References
- 1. Wu Q et al.. 2022. Hypoxia-inducible factors: master regulators of hypoxic tumor immune escape.. J Hematol Oncol 15(1):77 PMID: 35659268
- 2. Lu Y et al.. 2026. GAL3ST1-Mediated Histone Tyrosine Sulfation Induced by Cancer-Associated Fibroblasts Promotes Gastric Cancer Metastasis.. Cancer Res 86(10):2429-2446 PMID: 41686426
- 3. Seko A et al.. 2001. Molecular cloning and characterization of a novel human galactose 3-O-sulfotransferase that transfers sulfate to gal beta 1-->3galNAc residue in O-glycans.. J Biol Chem 276(28):25697-704 PMID: 11333265
- 4. Lo-Guidice JM et al.. 1995. Characterization of a sulfotransferase from human airways responsible for the 3-O-sulfation of terminal galactose in N-acetyllactosamine-containing mucin carbohydrate chains.. J Biol Chem 270(46):27544-50 PMID: 7499214
- 5. El-Fasakhany FM et al.. 2001. A novel human Gal-3-O-sulfotransferase: molecular cloning, characterization, and its implications in biosynthesis of (SO(4)-3)Galbeta1-4(Fucalpha1-3)GlcNAc.. J Biol Chem 276(29):26988-94 PMID: 11356829
- 6. Chandrasekaran EV et al.. 1999. Characterization of distinct Gal:3-O-sulfotransferase activities in human tumor epithelial cell lines and of calf lymph node GlcNAc : 6-O-sulfotransferase activity.. Glycoconj J 16(9):523-36 PMID: 10815989
- 7. Zhu X et al.. 2026. FUT1- and GAL3ST2-mediated cellular glycan remodeling broadly restricts sialic acid-dependent viral infections.. Proc Natl Acad Sci U S A 123(10):e2503728123 PMID: 41774787
- 8. Chandrasekaran EV et al.. 2004. Identification of physiologically relevant substrates for cloned Gal: 3-O-sulfotransferases (Gal3STs): distinct high affinity of Gal3ST-2 and LS180 sulfotransferase for the globo H backbone, Gal3ST-3 for N-glycan multiterminal Galbeta1, 4GlcNAcbeta units and 6-sulfoGalbeta1, 4GlcNAcbeta, and Gal3ST-4 for the mucin core-2 trisaccharide.. J Biol Chem 279(11):10032-41 PMID: 14701868
